0.45Open0.45Pre Close0 Volume1 Open Interest2.50Strike Price0.00Turnover0.00%IV-14.53%PremiumJul 19, 2024Expiry Date0.71Intrinsic Value100Multiplier11DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma3.98Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Stereotaxis Stock Discussion
Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart Treatment
Stereotaxis Receives CE Mark Recertification Under EU’s MDR Regulatory Framework
NEWS
First Heart Rhythm Patients in Southern Italy Treated with Advanced Robotic Technology
NEWS
Stereotaxis Reports 2024 First Quarter Financial Results
Stereotaxis (NYSE: STXS), a leader in surgical robotics for minimally invasive endovascular intervention, reported financial results for Q1 2024, ending March 31. Revenue grew 5% YoY to $6.9M, with system revenue at $2.6M and recurring revenue at $4.3M. Gross margin was 58%. Operating expenses were $8.7M, including $2.6M in non-cash stock compensation. Adjusted operating expenses were $6.1M, down from $6.9M YoY....
NEWS
Stereotaxis Announces Definitive Agreement to Acquire Access Point Technologies
Stereotaxis (NYSE: STXS), a leader in surgical robotics for minimally invasive endovascular intervention, announced a definitive agreement to acquire Access Point Technologies EP (APT). APT, based in Minnesota, develops electrophysiology catheters used in cardiac ablation procedures. This acquisition enhances Stereotaxis' catheter development, manufacturing capabilities, and provides comme...
MBOT MVST AVRO HTCR MVLA KC STXS PACW
$Microbot Medical(MBOT.US)$ $Microvast(MVST.US)$ $Avrobio(AVRO.US)$ $HeartCore Enterprises(HTCR.US)$ $Movella Holdings(MVLA.US)$ $Kingsoft Cloud(KC.US)$ $Stereotaxis(STXS.US)$ $PacWest Bancorp(PACW.US)$
No comment yet